Literature DB >> 30225708

Epac Proteins and Calmodulin as Possible Arrhythmogenesis Trigger in Alcoholic Cardiomyopathy.

L M Kozhevnikova1, I B Tsorin2, V N Stolyaruk2, I F Sukhanova1, M B Vititnova2, T D Nikiforova2, L G Kolik2, S A Kryzhanovskii3.   

Abstract

The expression of Epac proteins (exchange protein directly activated by cAMP) and calmodulin (CaM) was assessed by the content of the corresponding mRNA in biopsy specimens of cardiac atrium, left ventricle, and thoracic aorta of rats with alcoholic cardiomyopathy. In the myocardium, overexpression of Еpac1, Ерас2, and СаМ mRNA was found. The content of Epac2 mRNA in the left ventricle was elevated by 2.9 times (p=0.000001), in the left atrium by 3.2 times (p=0.00001), in the right atrium by 3 times (p=0.00001). In contrast to the myocardial tissue, the content of CaM mRNA in the thoracic aorta was not increased, but showed a tendency to decrease, when compared to the control values, while the level of Epac1 and Epac2 mRNA was increased. The assumption is made that regulatory proteins Epac and CaM can play a key role in arrhythmogenesis development under conditions of alcoholic cardiomyopathy.

Entities:  

Keywords:  Epac and calmodulin proteins; alcoholic cardiomyopathy; arrhythmogenesis; mRNA; myocardium

Mesh:

Substances:

Year:  2018        PMID: 30225708     DOI: 10.1007/s10517-018-4225-4

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  On the Mechanism of Cardioprotective Effect of Fabomotizole in Alcoholic Cardiomyopathy.

Authors:  S A Kryzhanovskii; L M Kozhevnikova; M B Vititnova; A O Efimova; V N Stolyaruk; I B Tsorin
Journal:  Bull Exp Biol Med       Date:  2021-05-29       Impact factor: 0.804

2.  The burden of alcoholic cardiomyopathy in China and different regions around the world.

Authors:  Jing Zhang; Hailing Liu; Xiang Bu; Qun Lu; Lu Cheng; Aiqun Ma; Tingzhong Wang
Journal:  J Glob Health       Date:  2022-07-30       Impact factor: 7.664

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.